Aclarion Inc Ordinary Shares ACON

Morningstar Rating
$2.38 −0.06 (2.46%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACON is trading at a LOCK|zR<pHK premium.
Price
$2.38
Fair Value
LOCK|YB%#dxN
Uncertainty
LOCK|&l DddCz
1-Star Price
LOCK|Q?rP^d
5-Star Price
LOCK|YG^@&!Z
Economic Moat
LOCK|@SD
Capital Allocation
—

Trading Information

Previous Close Price
$2.44
Day Range
$2.35–2.48
52-Week Range
$1.95–12.03
Bid/Ask
$2.33 / $2.43
Shares Outstanding
2.88M
Market Cap
$6.86M
Volume/Avg
15,749 / 52,807

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
42.04
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Value
Total Number of Employees
11

Valuation

Metric
ACON
Price/Earnings (Normalized)
—
Price/Book Value
0.34
Price/Sales
42.04
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
ACON
Quick Ratio
15.73
Current Ratio
16.20
Interest Coverage
—
Quick Ratio
ACON

Profitability

Metric
ACON
Return on Assets (Normalized)
−56.76%
Return on Equity (Normalized)
−59.83%
Return on Invested Capital (Normalized)
−64.44%
Return on Assets
ACON

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Veeva Systems Inc Class A
VEEV
LOCK|F&$!qDnKLOCK|h&$44B
Tempus AI Inc Class A common stock
TEM
—LOCK|>!$14B
BrightSpring Health Services Inc
BTSG
—LOCK|&%!>V$12B
Pro Medicus Ltd ADR
PMDIY
—LOCK|@V%^$11B
Pro Medicus Ltd
PMCUF
—LOCK|LhxYf$11B
Hinge Health Inc Ordinary Shares - Class A
HNGE
—LOCK|Kf&>%$8B
HealthEquity Inc
HQY
—LOCK|%?#c^$7B
M3 Inc
MTHRF
—LOCK|#L?ys$7B
M3 Inc ADR
MTHRY
—LOCK|p$cy$7B
Doximity Inc Class A
DOCS
—LOCK|@$$5B

Sponsor Center